Clinical trial
Genistein in Preventing Breast Cancer in Women at High Risk for Breast Cancer
NCT00290758 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00290758 |
|---|---|
| Title | Genistein in Preventing Breast Cancer in Women at High Risk for Breast Cancer |
| Official title | Phase IIB Trial of G-2535 (Unconjugated Isoflavones-100) in Women at High Risk for Breast Cancer |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug, Other |
| Interventions | placebo, genistein, laboratory biomarker analysis |
| Enrollment | 126 |
| Start date | Jan 1, 2006 |
| Primary completion | Mar 1, 2009 |
| Completion | Jul 1, 2009 |
| First posted | Feb 13, 2006 |
| Last update posted | Feb 8, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: